Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Frontiers in Oncology|May 13, 2022
Prognostic Factors and Survival Benefits of Antitumor Treatments for Advanced Non-Small Cell Lung Cancer Patients With Central Nervous System Metastasis With or Without Driver Genes: A Chinese Single-Center Cohort StudyXiaoxing Gao, Minjiang Chen, Xiaoyan Liu, et al.
Translational Lung Cancer Research|December 13, 2024
Lower respiratory tract microbiome is associated with checkpoint inhibitor pneumonitis in lung cancer patientsDongming Zhang, Junping Fan, Xiaoyan Liu, et al.
Ebiomedicine|October 29, 2024
Gut microbiome metabolites, molecular mimicry, and species-level variation drive long-term efficacy and adverse event outcomes in lung cancer survivorsXinyu Liu, Bo Lu, Hao Tang, et al.
Frontiers in Immunology|March 31, 2022
Characterization of Somatic Mutations That Affect Neoantigens in Non-Small Cell Lung CancerHongge Liang, Yan Xu, Minjiang Chen, et al.
International Journal of Cancer|June 5, 2024
Immune responses and reinfection of SARS-CoV-2 Omicron variant in patients with lung cancerChen Chen, Xiaoyun Zhou, Xiaoxing Gao, et al.
The Journal of Cell Biology|March 13, 2013
CUL4B promotes replication licensing by up-regulating the CDK2-CDC6 cascadeYongxin Zou, Jun Mi, Wenxing Wang, et al.
Thoracic Cancer|January 11, 2023
Circulating tumor cells PD-L1 expression detection and correlation of therapeutic efficacy of immune checkpoint inhibition in advanced non-small-cell lung cancerQing Zhou, Xiangning Liu, Ji Li, et al.
Translational Lung Cancer Research|June 15, 2026
Elevated baseline C-reactive protein predicts poorer survival in lung cancer: a 22-year retrospective cohort studyXiaomin Wei, Xiaoyan Liu, Mei Li, et al.
Current Oncology (Toronto, Ont.)|September 26, 2025
The Clinical Characteristics, Treatment, and Prognosis of Lung Cancer in Young Patients in the New Era of Cancer Treatment: A Retrospective and Comprehensive AnalysisXiaoyi Feng, Shengjie Li, Siyuan Yu, et al.
Heliyon|November 28, 2024
Longer duration of high-dose corticosteroids provides benefit for hospitalized COVID-19 patients with high oxygen requirementJunping Fan, Huaiya Xie, Yaqi Wang, et al.
Pageof 4